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Letter to the editor
Bilateral sympathectomy in a dilated cardiomyopathy model
Mateus Henrique Fernandes Martins da Silva, Raphael dos Santos Coutinho e Silva, 
Fernando Luiz Zanoni, Luiz Felipe Pinho Moreira
Cardiovascular diseases are still the main cause of 
death in the world. Among those, the leading indication 
to cardiac transplantation is dilated cardiomyopathy 
(DCM). This disease is caused by a variety of etiologies 
and culminate in ventricular remodeling, characterized by 
dilation of the ventricular chamber and systolic dysfunction, 
leading to congestive heart failure¹. 
Ventricular remodeling involves activation of the 
sympathetic and renin-angiotensin-aldosterone systems. 
As such, classic treatments include the use of beta-
blockers, angiotensin-converting enzyme inhibitors (ACEi) 
and mineralocorticoid receptor antagonists². As those 
treatments are continuous and only delay the development 
of the disease, it is important to look for better therapeutic 
options. In this sense, experimental models demonstrated 
benefits of sympathetic blockade on preserving ventricular 
function and preventing left ventricle remodeling after 
acute myocardial infarction³.
As presented in the XXXVII COMU in 2018, 
we evaluated the repercussions of the surgical inhibition 
of the sympathetic nervous system through bilateral 
sympathectomy and the clinical treatment with ACE 
inhibitors on dilated cardiomyopathy induced by 
doxorubicin in rats. 
For that, Wistar rats were randomly divided into 
4 groups, being: Control, BS, ACEi and a Sham group 
(negative control). The first 3 groups underwent induction 
of DCM by intraperitoneal injection of doxorubicin, 
while Sham group received intraperitoneal 0.9% saline 
solution weekly doses. At the fifteenth day after induction 
start, BS group rats were submitted to irreversible 
chemical sclerosis of the starlit ganglion through ethanol 
injection. From the same period, animals in the ACEi 
group received daily enalapril diluted in oral water until 
the end of the experimental protocol. Ten weeks after 
the beginning of DCM induction, four parameters were 
evaluated: left ventricular (LV) function with the analysis 
of pressure-volume loops, quantification of fibrosis degree, 
quantification of BCL-2 expression and morphometric 
measurements of the heart.
Function analysis showed an impairment in left 
ventricular function on control group, which validated our 
proposed model of dilated cardiomyopathy. Furthermore, 
control group hearts had an enlarged left ventricle, with 
a thinner left ventricular wall and increased extracellular 
fibrosis. Although ACEi group had prevented the 
enlargement of the ventricular chamber and reduced 
fibrosis, left ventricular ejection fraction was not reverted 
when compared to control group. Yet, BS group prevented 
the decay of left ventricular function, on top of the 
diminished fibrosis and decrease in ventricular dilation.  
Further analyses are being performed, and an article 
will be written and published.
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